Dr. Mitchell Weinberg, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 218
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: Perelman School of Med at the University of Pennsylvania
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
NJ license 25MA09041900 · NY license 239438 -
Cardiovascular Disease Physician
NY license 239438
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Staten Island University Hospital Staten Island, NY
Medical groups
- North Shore-Lij Medical PC (6,440 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 218
- Services billed
- 772
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 208 | 125 |
| New patient office or other outpatient visit, 45-59 minutes | 77 | 77 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 22 | 20 |
| Review by radiologist of abdominal aorta image | 21 | 20 |
| Review by radiologist of both arms or legs arteries image | 15 | 14 |
| Established patient office or other outpatient visit, 20-29 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Manhasset, NY | 26 |
| Rosuvastatin Calcium Other prescribers in Manhasset, NY | 24 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Manhasset, NY | 19 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 45 payments worth $27,568 in total to this clinician.
| Boston Scientific Corporation | $26,372 |
|---|---|
| Endologix LLC | $734 |
| Abbott Laboratories | $232 |
| Medtronic, Inc. | $194 |
| Shockwave Medical, Inc | $18.63 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.83 |
| Consulting Fee | $23,075 |
|---|---|
| Food and Beverage | $2,269 |
| Travel and Lodging | $2,224 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $9,100 |
| Boston Scientific Corporation Oct 23, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $4,125 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $2,100 |
| Boston Scientific Corporation Nov 20, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $1,500 |
| Boston Scientific Corporation Mar 20, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $1,400 |
| Boston Scientific Corporation Jun 26, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $1,125 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $1,000 |
| Boston Scientific Corporation Jan 23, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $750 |
| Boston Scientific Corporation Dec 5, 2025 | Travel and Lodging General - Therapies · General - Therapies_PI · travel to Houston, TX · in-kind | $745 |
| Boston Scientific Corporation Dec 4, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $525 |
All 22 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Dec 7, 2025 | Travel and Lodging General - Therapies · General - Therapies_PI · travel to Houston, TX · in-kind | $122 |
| Boston Scientific Corporation Dec 6, 2025 | Travel and Lodging General - Therapies · General - Therapies_PI · travel to Houston, TX · in-kind | $185 |
| Boston Scientific Corporation Dec 5, 2025 | Travel and Lodging General - Therapies · General - Therapies_PI · travel to Houston, TX · in-kind | $745 |
| Boston Scientific Corporation Dec 5, 2025 | Travel and Lodging General - Therapies · General - Therapies_PI · travel to Houston, TX · in-kind | $185 |
| Boston Scientific Corporation Dec 5, 2025 | Travel and Lodging General - Therapies · General - Therapies_PI · travel to Houston, TX · in-kind | $122 |
| Boston Scientific Corporation Dec 4, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $525 |
| Boston Scientific Corporation Dec 4, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $350 |
| Boston Scientific Corporation Nov 20, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $1,500 |
| Boston Scientific Corporation Oct 23, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $4,125 |
| Boston Scientific Corporation Oct 23, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $500 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $9,100 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $2,100 |
| Boston Scientific Corporation Sep 18, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $1,000 |
| Boston Scientific Corporation Aug 22, 2025 | Travel and Lodging JETSTREAM SC · JETSTREAM_PI · travel to Minneapolis, MN · in-kind | $276 |
| Boston Scientific Corporation Aug 21, 2025 | Travel and Lodging JETSTREAM SC · JETSTREAM_PI · travel to Minneapolis, MN · in-kind | $344 |
| Boston Scientific Corporation Aug 21, 2025 | Travel and Lodging JETSTREAM SC · JETSTREAM_PI · travel to Minneapolis, MN · in-kind | $244 |
| Boston Scientific Corporation Jun 26, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $1,125 |
| Boston Scientific Corporation Jun 26, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $125 |
| Boston Scientific Corporation Mar 20, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $1,400 |
| Boston Scientific Corporation Mar 20, 2025 | Consulting Fee General - Therapies · General - Therapies_PI | $350 |
| Boston Scientific Corporation Mar 13, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $125 |
| Boston Scientific Corporation Jan 23, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $750 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $163,183 in research payments for these studies, mostly to the institutions running them.
- NCT06656364--Esprit BTK Post-Approval Study
Abbott Laboratories - Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Microvention, Inc. · Status unknown · NCT02657707 - Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Boston Scientific Corporation · Recruiting · NCT04674969 - FlowTriever All-Comer Registry for Patient Safety and Hemodynamics
Stryker Corporation · Completed · NCT03761173
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.